Cold Plasma Implant Treatment Devices Market Insight-2030
The global cold plasma implant treatment devices market size was valued at $19.05 million in 2020, and is projected to reach $72.56 million by 2030 registering a CAGR of 14.70% from 2021 to 2030. Cold plasma is an efficient in deactivation of bacteria. A relatively new area is the use of these plasmas in dental applications. Furthermore, plasma treatment is potentially a novel tissue-saving technique, allowing irregular structures and narrow channels within the diseased tooth to be cleaned. Furthermore, cold plasma, also known as low-temperature plasma, is used in the modification of biomaterial surfaces. Low-temperature plasma is created by the conversion of a compound into gas, followed by ionization by applying energy in the form of heat, direct or alternating electric current, radiation, or laser light. Oxygen, nitrogen, hydrogen, or agon are the commonly used plasma gas sources. In addition, low-temperature plasma is a promising method for inhibiting the growth of microorganisms, an effective alternative to conventional methods such as high temperatures, radiation, filtration, and desiccation (drying), which have numerous drawbacks.
Increase in elderly population, technological advancements in cold plasma implant treatment devices, surge in orthopedic conditions, rise in dental caries, and enhanced antimicrobial efficacy, and prevention of cross-contamination drive the cold plasma implant treatment devices market growth. Furthermore, the market experiences continuous growth due to increase in applications of cold plasma in wound healing, cancer treatment, and infective diseases. However, high cost and lack of skilled professional hamper the market growth. Conversely, rise in awareness related implant treatment devices and high growth potential in emerging markets are expected to provide potential growth opportunities for the market. Furthermore, innovations in implant industry significantly contribute toward the growth of the market.
The outbreak of COVID-19 has disrupted workflow in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several subdomains of healthcare. Moreover, COVID-19 has negatively impacted the cold plasma implant treatment devices market. The lockdown has impacted every type of business across the globe. For instance, nonessential businesses such as retail business that operates with a physical location that the public accesses are closed. Furthermore, nonessential construction were halted, and recreational and entertainment businesses such as gyms, movie theaters, art centers, race tracks, salon, and public & private social clubs were closed under the lockdown. However, essential businesses such as grocery stores, chemist stores, and hospitals were functional during lockdown.
Healthcare or public health personnel were exempted from the lockdown. For instance, these include workers who perform critical clinical research, development, and testing needed for COVID-19 response. The exemption include healthcare providers and caregivers such as physicians, dentists, psychologists, mid-level practitioners, nurses & assistants, and laboratory professionals.
The outbreak disrupted and forced several industries to halt their activities temporarily, including several subdomains of healthcare. Similarly, the cold plasma implant treatment devices industry was impacted negatively. Major players in the market were facing supply chain interruptions and the demand for products was significantly reduced.
In 2020, hospitals and clinics experienced a notable decline in surgical procedural volumes worldwide, as healthcare systems redirected their resources to meet rise in requirements of COVID-19 patients. In addition, public health bodies across the world have suggested rescheduling or suspending elective surgeries throughout the pandemic phase. In addition, several orthopedic and dental elective procedures were halted.
By Application
Dental Implants segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Cold Plasma Implant Treatment Devices Market Segmentation
The global cold plasma implant treatment devices market is segmented into application, type, end user, and region. Depending on application, the market is categorized into orthopedic implants and dental implants. On the basis on type, it is bifurcated into handheld devices and commercial systems. By end user, the market is bifurcated into medical devices companies, hospitals & clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
On the basis of type, the commercial system garnered the largest share of the global cold plasma implant treatment devices market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in commercial systems which are used on large scale such as in pharmaceutical or medical device companies for implant treatment.
By Type
Commercial Systems segment is projected as one of the most lucrative segment.
Snapshot Of North America Cold Plasma Implant Treatment Devices Market
North America garnered the largest share of the global cold plasma implant treatment devices market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of large population base, increase in awareness cold plasma implant treatment, and rise in healthcare expenditure.
By Region
Asia-Pacific region would exhibit the highest CAGR of 5.6% during 2021-2030.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the global cold plasma implant treatment devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the cold plasma implant treatment devices market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing cold plasma implant treatment devices market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products the market used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the cold plasma implant treatment devices market.
Cold Plasma Implant Treatment Devices Market Report Highlights
| Aspects | Details |
 By Application |
|
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | AG AFS ENTWICKLUNGS+VERTRIEBS GMBH, EUROPLASMA NV, TERRAPLASMA GMBH, PLASMAWISE, RELYON PLASMA GMBH, TANTEC A/S, NOVAPLASMA, PLASMA MEDICAL SYSTEMS, ADTEC PLASMA TECHNOLOGY, NORDSON CORPORATION |
Analyst Review
Increase in elderly population, technological advancements in cold plasma implant treatment devices, surge in orthopedic conditions, rise in dental caries, and enhanced antimicrobial efficacy, and prevention of cross-contamination drive the market growth. Furthermore, the market experiences continuous growth due to increase in applications of cold plasma in wound healing, cancer treatment, and infective diseases. However, high cost and lack of skilled professional hamper the market growth. Conversely rise in awareness related implant treatment devices and high growth potential in emerging markets are expected to provide potential growth opportunities for the market. Furthermore, innovations in implant industry significantly contribute toward the growth of the market.
North America garnered the largest share of the global cold plasma implant treatment devices market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of large population base, increase in awareness cold plasma implant treatment, and rise in healthcare expenditure. On the contrary, Asia-Pacific is expected to serve as a lucrative market for cold plasma implant treatment devices in the near future, owing to increase in demand for cold plasma technology. Moreover, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region, which is expected to foster the marker growth. In addition, rise in disposable income and increase in target population base are likely to contribute to the overall market growth.
.
The total market value of Global Cold Plasma Implant Treatment Devices Market is $19.05 million in 2020.
The forcast period for Global Cold Plasma Implant Treatment Devices Market is 2021 to 2030
The market value of Global Cold Plasma Implant Treatment Devices Market in 2021 is $21.04 million.
The base year is 2020 in Global Cold Plasma Implant Treatment Devices Market
Top companies such as AdtecRF, AFS Entwicklungs+Vertriebs GMBH, Europlasma NV, Plasmaone Medical Systems, Plasmawise, Relyon Plasma GMBH, Novaplasma, Nordson Corporation, Tantec A/S and Terraplasma GMBH held a high market position in 2020.
Based on age group, the market is divided into adults, children and infants. Among these segments, the adult segment is expected to be the fastest growing segment during the forecast period. The segment growth can be attributed to increasing geriatric population who are more prone to orthopedic injuries as compared to children.
The factors driving the Global Cold Plasma Implant Treatment Devices Market are increase in elderly population, technological advancements in cold plasma implant treatment devices, surge in orthopedic conditions, rise in dental caries, and enhanced antimicrobial efficacy, and prevention of cross-contamination drive the market growth.
North America garnered the largest share of the global cold plasma implant treatment devices market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of large population base, increase in awareness cold plasma implant treatment, and rise in healthcare expenditure
Loading Table Of Content...
